According to a study published online in the Proceedings of the National Academy of Sciences, an FDA-approved anti-epileptic drug has been found to reverse memory loss in a mouse model of Alzheimer's disease . The study, conducted by researchers at the Gladstone Institutes, also found that the drug, called levetiracetam, alleviates other Alzheimer's related impairments by suppressing abnormal brain activity. Levetiracetam is often prescribed to individuals who suffer from epilepsy. At present, around 5...
More...
More...